Where is Health Technology Assessment Going?

Chrissie Fletcher talks about Innovation in Clinical Design, Analysis and Reporting from a Health Technology Assessment (HTA) perspective. She discusses how she sees health economists and statisticians interacting going forwards, why there is so much emphasis on reporting for reimbursement and whether she expects pharma companies will try and do this more in-house, in the future. She also offers her thoughts on health economists who don’t have a statistical background, how she sees the HTA evolving and its place in the next 5-10 years. Chrissie will be speaking at the Innovation in Clinical Design, Analysis and Reporting conference, due to take place from 6th – 8th December in London. For anyone interested in attending, there is still time to book, please call: 0800 652 2363, email enquire@iqpc.co.uk or visit the website: www.clinicalreporting.co.uk